Baseret på disse data forventes ISENTRESS ikke at påvirke farmakokinetikken af lægemidler, der er substrater for disse enzymer eller P- glycoprotein.
Based on these data, ISENTRESS is not expected to affect the pharmacokinetics of medicinal products that are substrates of these enzymes or P-glycoprotein.